Pipeline
Powered by Molecule Pro™
| Program | Target | Indication | Discovery | Optimization | IND-enabling | Phase I | Phase II | Phase III | Partner |
|---|---|---|---|---|---|---|---|---|---|
MDR-001 | GLP-1RA | Obesity | Potential Best-in-Class | ||||||
| HBP | |||||||||
| Type 2 Diabetes | Potential Best-in-Class | ||||||||
MRANK-116 | Undisclosed | Obesity | |||||||
MRANK-111 | CB1 | Obesity | |||||||
MRANK-119 | GIP | Obesity | |||||||
MRANK-808 | Undisclosed | Obesity | |||||||
MRANK-106 | Wee1 & YES1 | Oncology | |||||||
MRANK-101 | P53 | Oncology |